Course of Care of a Multiple Sclerosis Patient in the Context of Pharmacotherapy
Multiple sclerosis (SM) is an incurable, advancing, demyelinating illness with inflammatory background. It constitutes the most frequent cause of disability among young people, between 20 and 40 years of age. Despite the identification of multiple factors causing the disease, its pathomechanism has...
Saved in:
Main Authors: | Anna Smelkowska, Maria Wilkiewicz, Barbara Grabowska-Fudala, Krystyna Jaracz |
---|---|
Format: | Article |
Language: | English |
Published: |
Państwowa Akademia Nauk Stosowanych we Włocławku
2015-06-01
|
Series: | Pielęgniarstwo Neurologiczne i Neurochirurgiczne |
Subjects: | |
Online Access: | https://apcz.umk.pl/PNIN/article/view/38660 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nursing Care of Patients with Multiple Sclerosis During Immunomodulatory Treatment of First-line Drugs
by: Maria Wilkiewicz, et al.
Published: (2013-06-01) -
Immunomodulating Treatment of Multiple Sclerosis — the Tasks and Role of a Neurological Nurse
by: Anna Smelkowska, et al.
Published: (2018-06-01) -
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01) -
Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy
by: Awada Z, et al.
Published: (2024-12-01) -
Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials
by: Eoin Moloney, et al.
Published: (2024-12-01)